Prostate Cancer Japan Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary D. Western Therapeutics Institute, Inc. (DWTI) is a pharmaceutical company. The company discovers and develops new drugs. Its products include K-134, K-115, HMN-214, and HMN-1129. DWTI's K-134 is a clinical candidate for anti-platelet drug which is used for the treatment of arteriosclerosis obliterans. ...

Industries: Therapy | Countries: Japan

Epilepsy Therapeutics Market in the APAC Region 2015-2019

Epilepsy Therapeutics Market in the APAC Region 2015-2019

  • $ 2 500
  • Industry report
  • by Infiniti Research Limited
  • December 2014
  • 86 pages

About Epilepsy Therapeutics Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying ...

Industries: Therapy | Countries: China, Australia, Japan, India, World, Asia

Respiratory Therapy News DECEMBER 2014

Respiratory Therapy News DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 8 pages

Industry Brief - BeyondSpring To Initiate Plinabulin Phase III Trial In NSCLC Industry Brief - FDA Grants Fast Track Designation To Novavax' RSV F Vaccine Industry Brief - FDA Grants QIDP Designation To Bayer's Amikacin Inhale/Ciprofloxacin DPI Industry Brief - CHMP Issues Positive Opinion For BI's Nintedani ...

Industries: Therapy | Countries: Canada, Spain, Italy, Germany, Japan, Europe, United Kingdom, World

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 105 pages

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014', provides an overview of the Chemotherapy Induced Neutropenia's therapeutic pipeline. This report provides comprehensive information on the therapeutic ...

Industries: Therapy | Countries: World, Japan

 Nasal Congestion-API Insights, 2014

Nasal Congestion-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Therapy | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Canada, Japan

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

  • $ 4 995
  • Industry report
  • by GBI Research
  • October 2014
  • 98 pages

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies Summary GBI Research, the leading business intelligence provider, has released its latest research, "Colorectal Cancer Therapeutics in Asia-Pacific Markets ...

Industries: Therapy | Countries: World, Australia, India, Japan, China

Japan Compression Therapy Market Outlook to 2020

Japan Compression Therapy Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 65 pages

Japan Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "Japan Compression Therapy Market Outlook to 2020", provides key market data on the Japan Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Therapy | Countries: Japan

Asia-Pacific Compression Therapy Market Outlook to 2020

Asia-Pacific Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • October 2014
  • 268 pages

Asia-Pacific Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Compression Therapy Market Outlook to 2020", provides key market data on the Asia-Pacific Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average ...

Industries: Therapy | Countries: South Korea, Australia, China, India, Japan, Asia, World, Oceania

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • October 2014
  • 69 pages

Key Findings •Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth place in Europe and the rest of the world. •An estimated xxmillion people are affected by COPD globally. By 2020, COPD is projected to be the third leading cause ...

Industries: Therapy | Countries: World, United States, Europe, Australia, United Kingdom, Iceland, Denmark, Japan

Respiratory Therapy News OCTOBER 2014

Respiratory Therapy News OCTOBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • October 2014
  • 28 pages

Industry Trend Analysis - Respiratory Market Stratification Inevitable, Augmented By ERS Revelations Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory Industry Trend Analysis - Race For First US IPF Treatment Is A Dead Heat Industry Brief - Novavax Initiates ...

Industries: Therapy | Countries: United States, Greece, Germany, Japan, Europe, World, Asia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.